RE:RE:RE:Before the AGM"I expect micro cap stocks to grow far more than 10% per year (most investors do)."
CZO has grown far, far more than 10% per year. In addition to the 10% growth of the base business the avenanthramide pill has been developed(including a second formulation) and a clinical trial program has been approved by Health Canada. The fibrosis drug is before a go / no go decision this summer. Summer is only about one month away. PGX has advanced from the prototype PGX-OBG to second generation carriers PGX-YBG and PGX-Alginate. These new carriers blew the industry gold standard out of the water. CZO may even have a Trojan Horse that can hijack macrophages for delivery of drug to tissue. Dr. Kjetil Ask, now a leading scientist with the world's largest drug company, has expressed his excitement about PGX-YBG. The Canadian government also continues to provide funding.
One reason that you can't see and appreciate the growth and transition of this company to a biopharma is that I believe you have been a victim of a smear campaign against this company. The evidence of CZO's transition to a biopharma is quite apparent if you ignore all of the noise being posted on this message board. Why not post on the transition CZO has undertaken and its progress instead of bashing Gilles as some here want you to with no acknowledgement of CZO's progress and achievements.